Advertisement
YOU ARE HERE: LAT HomeCollectionsFederal Circuit
IN THE NEWS

Federal Circuit

BUSINESS
August 16, 2002 | Bloomberg News
Teva Pharmaceutical Industries Ltd. may keep selling a low-cost version of Relafen after a U.S. appeals court upheld a ruling that invalidated a GlaxoSmithKline patent on the anti-inflammatory drug. Teva began selling a generic version of the drug, which generated $265 million a year for Middlesex, England-based Glaxo, in August 2001, after a federal judge invalidated the patent for the drug's active ingredient, nabumetone. The U.S.
Advertisement
BUSINESS
October 28, 2006 | From Reuters
The U.S. Supreme Court agreed to consider whether Microsoft Corp. should have to pay damages overseas for infringing a speech recognition software patent owned by AT&T Inc. The high court granted Microsoft's petition to review an appeals court ruling that held that AT&T could seek royalties based on the foreign manufacture and sale of infringing software products.
BUSINESS
December 13, 2008 | Bloomberg News
Bristol-Myers Squibb Co. and Sanofi-Aventis won an appeals court ruling Friday that will help them block generic competition to the blood thinner Plavix, the world's No. 2 selling-drug, in the U.S. until 2011. Bristol-Myers and Sanofi said that as a result of the ruling by a three-judge panel of the U.S. Court of Appeals for the Federal Circuit in Washington, they will seek reimbursement from Canadian drug maker Apotex Inc.
BUSINESS
June 13, 2009 | TIMES WIRE REPORTS
Dish Network Corp., which has won a temporary legal reprieve from halting its digital video recording service, is abusing the legal system with years of delays while it continues to infringe TiVo Inc.'s technology, an industry trade group said. The Assn. for Competitive Technology Inc., which represents smaller technology companies as well as Microsoft Corp., Oracle Corp. and EBay Inc., claims in a brief filed with the U.S. Court of Appeals for the Federal Circuit that Dish and EchoStar Communications Corp.
BUSINESS
April 9, 2003 | From Bloomberg News
Schering-Plough Corp. argued before a U.S. appeals court that a judge erred in invalidating a patent that warded off generic competition to Claritin, once the company's top seller. The allergy drug, which accounted for almost a third of company revenue in 2001, is now sold as a nonprescription drug. Meanwhile, Wyeth is selling a competing generic equivalent, Alavert, and other rivals are expected to follow unless the U.S.
BUSINESS
October 2, 2000 | Bloomberg News
Amazon.com Inc.'s fight to bar rival Barnesandnoble.com Inc. from using a patented single-click online purchasing method goes before a federal appeals court, which will hear arguments today in a case that could shape the future of Internet business. The U.S. Court of Appeals for the Federal Circuit in Washington will decide whether to lift a preliminary injunction blocking Barnesandnoble.com from using technology that enables online purchases with one click of a computer mouse. Amazon.
BUSINESS
April 26, 1986 | LESLIE BERKMAN
Hughes Tool Co. of Houston filed an appeal Friday, seeking to increase the $204.6-million judgment it was awarded last month in its patent-infringement lawsuit against Irvine-based Smith International Inc. Smith already has filed its own appeal, claiming that the award--determined by U.S. District Judge Harry L. Hupp--is too large. Both Smith's appeal and Hughes' cross appeal will be heard by the U.S. Court of Appeals for the Federal Circuit in Washington.
Los Angeles Times Articles
|